Latest / Lafayette Louisiana News Today | 2 Min News | The Daily News Now!
Moderna’s Melanoma Vaccine Shows Promise | Lafayette Louisiana News
Moderna’s latest cancer vaccine data for melanoma is electrifying—when paired with standard treatment, it may slash recurrence rates in advanced cases. After surgery, over a third of patients see cancer return within two years, but this personalized mRNA jab, built from the tumor’s genetic code, trains the immune system to hunt down lingering cells. It’s not a prevention tool, but a powerful add-on therapy aimed at stopping relapse. Early results show strong long-term survival without recurrence—a major leap forward in melanoma care, though more research is still needed. Listen in comfort:Get…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.